Mingorance C - Search Results

1

Endothelial dysfunction and aging: an update.

Herrera MD, Mingorance C, Rodríguez-Rodríguez R, Alvarez de Sotomayor M. Herrera MD, et al. Among authors: mingorance c. Ageing Res Rev. 2010 Apr;9(2):142-52. doi: 10.1016/j.arr.2009.07.002. Epub 2009 Jul 18. Ageing Res Rev. 2010. PMID: 19619671 Review.

2

Pharmacological effects and clinical applications of propionyl-L-carnitine.

Mingorance C, Rodriguez-Rodriguez R, Justo ML, Herrera MD, de Sotomayor MA. Mingorance C, et al. Nutr Rev. 2011 May;69(5):279-90. doi: 10.1111/j.1753-4887.2011.00387.x. Nutr Rev. 2011. PMID: 21521230 Review.

3

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Mingorance C, Rodríguez-Rodríguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD. Mingorance C, et al. Vasc Health Risk Manag. 2011;7:169-76. doi: 10.2147/VHRM.S14356. Epub 2011 Mar 28. Vasc Health Risk Manag. 2011. PMID: 21490942 Free PMC article. Review.

4

Chronic treatment with the cannabinoid 1 antagonist rimonabant altered vasoactive cyclo-oxygenase-derived products on arteries from obese Zucker rats.

Mingorance C, de Sotomayor MA, Marhuenda E, Herrera MD. Mingorance C, et al. J Cardiovasc Pharmacol. 2010 Nov;56(5):560-9. doi: 10.1097/FJC.0b013e3181f7141a. J Cardiovasc Pharmacol. 2010. PMID: 20729749

5

Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.

Mingorance C, Duluc L, Chalopin M, Simard G, Ducluzeau PH, Herrera MD, Alvarez de Sotomayor M, Andriantsitohaina R. Mingorance C, et al. PLoS One. 2012;7(3):e34268. doi: 10.1371/journal.pone.0034268. Epub 2012 Mar 23. PLoS One. 2012. PMID: 22457831 Free PMC article.

6

Effects of chronic treatment with the CB1 antagonist, rimonabant on the blood pressure, and vascular reactivity of obese Zucker rats.

Mingorance C, Alvarez de Sotomayor M, Jiménez-Palacios FJ, Callejón Mochón M, Casto C, Marhuenda E, Herrera MD. Mingorance C, et al. Obesity (Silver Spring). 2009 Jul;17(7):1340-7. doi: 10.1038/oby.2009.20. Epub 2009 Feb 19. Obesity (Silver Spring). 2009. PMID: 19553924 Free article.

7

[Mechanism involved in aged-related endothelial dysfunction].

Mingorance C, Herrera MD, Alvarez De Sotomayor M. Mingorance C, et al. Med Clin (Barc). 2009 Jan 24;132(2):62-9. doi: 10.1016/j.medcli.2008.09.011. Epub 2008 Dec 3. Med Clin (Barc). 2009. PMID: 19174073 Review. Spanish.

8

Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats.

Alvarez de Sotomayor M, Vega S, Mingorance C, Marhuenda E, Herrera MD. Alvarez de Sotomayor M, et al. Among authors: mingorance c. Pharmacology. 2008;82(2):89-96. doi: 10.1159/000135629. Epub 2008 May 29. Pharmacology. 2008. PMID: 18509252

9

Cedrelopsis grevei improves endothelial vasodilatation in aged rats through an increase of NO participation.

Mingorance C, Andriantsitohaina R, Alvarez de Sotomayor M. Mingorance C, et al. J Ethnopharmacol. 2008 Apr 17;117(1):76-83. doi: 10.1016/j.jep.2008.01.019. Epub 2008 Feb 2. J Ethnopharmacol. 2008. PMID: 18325702

10

Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries.

Alvarez de Sotomayor M, Mingorance C, Andriantsitohaina R. Alvarez de Sotomayor M, et al. Among authors: mingorance c. Atherosclerosis. 2007 Jul;193(1):112-20. doi: 10.1016/j.atherosclerosis.2006.08.041. Epub 2006 Sep 18. Atherosclerosis. 2007. PMID: 16979646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results